M
MDCN
vs
S&P 500
S&P 500
Over the past 12 months, MDCN has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +12% growth.
Stocks Performance
MDCN vs S&P 500
Performance Gap
MDCN vs S&P 500
Performance By Year
MDCN vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Medican Enterprises Inc
Glance View
Medican Enterprises, Inc. is a bio-pharmaceutical company, which engages in the production, cultivation, and wholesale distribution of cannabis related products. The company is headquartered in Las Vegas, Nevada and currently employs 3 full-time employees. The company went IPO on 2000-05-22. The firm is engaged in wholesale medical marijuana production, cultivation, and wholesale distribution of cannabis related products. Through joint ventures with development partners all over Canada and the United States, the Company builds and operates medical marijuana cultivation and research centers. The firm focuses on cultivating approximately five strains of cannabis, including High tetrahydrocannabinol (THC)/Low Cannabidiol (CBD), Medium THC/Low CBD, Medium THC/Medium CBD and Low TCH/High CBD. The firm provides strategic planning, valuation, project debt and corporate finance solutions to its joint venture partners in order to capitalize on the growing medical marijuana market and fund multiple facilities. The firm's subsidiary, Medican Systems Inc., is a licensed producer of medical marijuana under the new program marijuana for medical purposes regulation.
